Seeyond Biogen Inc. Transaction History

Seeyond

$1.03 Billion
Q4 2022

A detailed history of Seeyond transactions in Biogen Inc. stock. As of the latest transaction made, Seeyond holds 8,900 shares of BIIB stock, worth $1.33 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

8,900

Previous 25,211 64.7%

Holding current value

$1.33 Million

Previous $6.73 Million 63.39%

% of portfolio

0.24%

Previous 0.81%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $4.12 Million - $5 Million	-16,311 Reduced 64.7%	8,900 $2.46 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $2.98 Million - $4.11 Million	15,321 Added 154.91%	25,211 $6.73 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $1.74 Million - $2.07 Million	9,283 Added 1529.32%	9,890 $2.02 Million
Q1 2022 May 13, 2022	BUY	$193.77 - $244.14 $9,494 - $11,962	49 Added 8.78%	607 $127,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $112,631 - $144,748	503 Added 914.55%	558 $133,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $2.19 Million - $2.86 Million	-7,752 Reduced 99.3%	55 $15,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $375,809 - $601,744	1,451 Added 22.83%	7,807 $2.7 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $741,969 - $869,260	-3,054 Reduced 32.45%	6,356 $1.78 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $474,173 - $713,749	2,007 Added 27.11%	9,410 $2.3 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $69,369 - $80,096	-262 Reduced 3.42%	7,403 $2.1 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $1.19 Million - $1.58 Million	4,618 Added 151.56%	7,665 $2.05 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $121,251 - $153,809	451 Added 17.37%	3,047 $545,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $278,816 - $385,256	-1,267 Reduced 32.8%	2,596 $770,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $207,437 - $232,661	954 Added 32.79%	3,863 $899,000
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $297,576 - $328,014	-1,357 Reduced 31.81%	2,909 $680,000
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $509,485 - $796,894	2,351 Added 122.77%	4,266 $1.01 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $533,327 - $675,516	1,915 New	1,915 $576,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.

Account